摘要
目的研究尤瑞克林治疗急性期脑梗死的疗效及其对血清C-反应蛋白（CRP）的影响。方法选取2008年10月至2009年10月在太原市中心医院神经内科住院患者60例随机分为治疗组（丹参川芎嗪注射液＋脑蛋白水解物注射液＋阿司匹林肠溶片十尤瑞克林）和对照组（丹参川芎嗪注射液＋脑蛋白水解物注射液＋阿司匹林肠溶片），观察两组治疗前后神经功能改善情况和血清CRP的水平。结果治疗组和对照组的总有效率均显著提高，治疗组优于对照组（P〈0．01）；血清CRP水平均明显降低，且治疗组CRP水平更低（P〈0．05）。结论尤瑞克林可以改善急性期脑梗死患者的症状及体征。
Objective To research the curative effect of urinary kal]idinogenase on the changes of serum C-reactive protein （CRP） in patients with acute cerebral infarction. Methods Sixty cases of acute cerebral infarction were randomly divided into treatment group （treated with salviae mihiorrhizae and ligustrazine hydrochloride injection ＋ cerebroprotein hydrolysate injection ＋ aspirin ＋ urinary kallidinogenase） and control group（ treated with salviae mihiorrhizae and ligustrazine hydrochloride injection ＋ cerebroprotein hydrolysate injection ＋ aspirin）, the changes of neural function and serum level of CRP were compared between the two groups. Results Total effective rate of the two groups were both significantly increased, but the treatment group was better than control group （P 〈 0. 01 ） ; Serum levels of CRP were reduced, and the treatment group Was significantly lower than control group （P 〈 0. 05）. Conclusions Urinary kallidinogenase could significantly improve symptoms and signs in patients with acute cerebral infarction.
出处
《中国实用医刊》
2013年第5期11-12,共2页
Chinese Journal of Practical Medicine
关键词
急性期脑梗死
尤瑞克林
C-反应蛋白
Acute cerebral infarction
Urinary kallidinogenase
C-reactive protein
